HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Brown, P. H. Articles by Kingston, E. Search for Related Content PubMed PubMed Citation Articles by Brown, P. H. Articles by Kingston, E.

Radiation Dose Calculation for Tc-99m HIDA in Health and Disease

Veterans Administration Medical Center and University of Oregon Health Sciences Center, Portland, Oregon

Correspondence: For reprints contact: Paul H. Brown, Nuclear Medicine Service, VA Medical Ctr., 3710 SW U.S. Vet. Hosp. Rd, Portland, OR 97201.

ABSTRACT

Radiation dose from Tc-99m HIDA has been calculated for normal subjects and for patients with various hepatobiliary diseases classified into four groups based on serum bilirubin level. The calculation was performed on biokinetic radioactivity data from blood, urine, liver, gallbladder, and intestines, using a biological approach that included a catenary model of the digestive organs. For normal subjects the critical organs were the gallbladder and the upper and lower large intestine, with doses of 910, 300, 200 mrad/mCi, respectively. The bone marrow, ovaries, and testes received 24, 62, and 4 mrad/mCi. For Group 4 patients with severe hepatobiliary disease (bilirubin >10 mg/dl), the critical organs were the kidney, urinary bladder, and gallbladder, with doses of 130, 110, and 100 mrad/mCi. The bone marrow, ovaries, and testes received 9, 13, and 5 mrad/mCi. Thus the critical organs and over all radiation doses to organs change between health and disease.